Corticosteroids Market Research: Growth Projections and Trends 2030

Uncover key drivers, emerging technologies, and competitive movements shaping the corticosteroids market from 2026–2035 with trusted insights from The Business Research Company

What market expansion outlook does the Corticosteroids Market show for the 2026–2030 period?

The corticosteroids market size has experienced significant growth in recent years. It is anticipated to expand from $5.93 billion in 2025 to $6.33 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.7%. This historical growth can be attributed to several factors, including the increasing occurrence of asthma and allergies, the established clinical effectiveness of corticosteroids, the widespread adoption of steroid therapies in hospitals, enhanced awareness of inflammatory disease management, and the expansion of pharmaceutical manufacturing capacity.

The corticosteroids market size is projected to undergo significant expansion in the upcoming years. It is expected to reach $8.34 billion by 2030, with a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is primarily driven by an increasing prevalence of autoimmune and respiratory diseases, the development of more secure steroid formulations, a global aging population, enhanced healthcare access in emerging economies, and heightened investment in corticosteroid research. Notable trends for the forecast period include the emergence of targeted corticosteroid formulations, the implementation of low dose and short duration therapies, a rise in the use of topical and inhaled corticosteroids, combination therapies incorporating bronchodilators, and an expanding application in acute respiratory care.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp

What Drivers Are Shaping The Development Of The Corticosteroids Market?

The corticosteroid market is expected to expand due to the escalating need for cancer treatment. Cancer care involves multiple therapeutic approaches, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted treatments, all aimed at eliminating malignant cells and easing patient discomfort. This escalating demand for cancer interventions is fueled by factors such as a growing prevalence of cancer, enhanced public awareness and screening initiatives, better availability of healthcare, and the provision of supportive services. Corticosteroids play a crucial role by mitigating symptoms and improving the tolerance of various cancer therapies, which in turn leads to better patient results and reinforces the need for extensive cancer support. As an illustration, in May 2024, the National Health Service (NHS), the UK’s healthcare system, announced record-high treatment activity, with more than 1,400 patients starting cancer treatment daily on working days. Moreover, from April 2023 to March 2024, close to 340,000 individuals commenced their initial cancer therapy. Consequently, the increasing requirement for cancer treatment directly propels the expansion of the corticosteroid market.

Which Segments Are Contributing To The Growth Of The Corticosteroids Market?

The corticosteroids market covered in this report is segmented –

1) By Product: Glucocorticoids, Mineralocorticoids

2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications

3) By End User: Hospitals, Clinics, Research Institutes, Other End Users

Subsegments:

1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids

2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids

What Upcoming Trends Are Likely To Define The Future Path Of The Corticosteroids Market?

Leading companies in the corticosteroids market are developing innovative products, such as rescue medications, to broaden their customer reach, increase sales, and boost revenue. A rescue medication is a type of treatment or drug designed to provide rapid and immediate relief from acute and severe symptoms of a medical condition or a sudden worsening of a chronic condition. For instance, in January 2023, AstraZeneca PLC, a UK-based pharmaceutical company, announced that the FDA approved Airsupra (albuterol/budesonide). A distinguishing characteristic of this product is its classification as the first-in-class pressurized metered-dose inhaler (pMDI), which functions as a fixed-dose combination rescue medication. It contains albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS) known for its anti-inflammatory properties. This product is indicated for individuals aged 18 years and older and can be used on an as-needed basis for either treating or preventing bronchoconstriction. It also contributes to lowering the risk of asthma exacerbations. This specific combination is currently available in the United States and is under development by AstraZeneca in collaboration with Avillion.

Who Are The Core Companies Influencing Trends In The Corticosteroids Market?

Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report

Which Regions Are Projected To Dominate The Corticosteroids Market In The Coming Years?

North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Corticosteroids Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=2832&type=smp

Browse Through More Reports Similar to the Global Corticosteroids Market 2026, By The Business Research Company

Drugs For Immunotherapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Metabolic Disorders Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report

Musculoskeletal Disorder Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/musculoskeletal-disorder-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795